Rare diseases
Investigational molecules
Locations
Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
LithuaniaStudy of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections
LithuaniaStudy on FX06 for Improving Acute Respiratory Distress Syndrome in Patients
LithuaniaStudy of Debio 4228 for Patients with Advanced or Metastatic Prostate Cancer
LithuaniaStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
LithuaniaStudy on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis
LithuaniaStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
LithuaniaStudy on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis
LithuaniaStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
LithuaniaStudy on the Safety and Effects of OMS906 for Patients with C3 Glomerulopathy and Idiopathic Immune Complex-Mediated Glomerulonephritis
LithuaniaStudy on NECVAX-NEO1 with PD-1/PD-L1 Inhibitors for Patients with Advanced Solid Tumors
LithuaniaStudy on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
LithuaniaTell us about your condition – we search every trial in Europe and connect you with the right site.
